These investigations documented that plasma MPO-DNA complexes were found to be elevated in COVID-19 patients and correlated with disease severity, as evidenced by a higher sequential organ failure assessment (SOFA) score, incidence of intubation and death, and lower PaO2/FiO2 ratios (79, 108). The gene discussed is MPO; the disease is COVID-19.